Skip to content Skip to navigation

New Alzheimer's drug slightly slows cognitive decline. Experts say it's not a silver bullet.

A newly approved drug targets sticky plaques of protein in the brain to treat Alzheimer's
Jan 20 2023

Experts, including Stanford researchers, weigh in on whether the newly approved Alzheimer's treatment lecanemab is worth taking.